Day: June 28, 2022

Statkraft has updated its growth strategy within renewable energy with new, more ambitious targets towards 2030. The strategy increases the annual growth rate for onshore wind, solar and battery storage from 2.5-3 GW in 2025 to 4 GW in 2030. At the same time, growth ambitions for hydropower, offshore wind and green hydrogen are increased. In total, Statkraft aspires to have developed 30 GW new renewable capacity by 2030. That could increase Statkraft’s annual power generation by up to 50 percent from today, to around 100 TWh per year by the end of the decade. 100 TWh equals almost three times the annual power consumption of Denmark. “The need for renewable energy is increasing sharply, both to meet net zero targets, cover new power consumption in Norway and strengthen European energy security. Combined with increased investment capacity,...

Dreamstation 1 deviceJune 28, 2022 Testing in accordance with ISO 18562 and ISO 10993 standards conducted by five certified, independent testing laboratories in the US and Europe Amsterdam, the Netherlands – On June 14, 2021, Royal Philips’ (NYSE: PHG; AEX: PHIA) subsidiary Philips Respironics, initiated a voluntary recall notification/field safety notice* to address potential health risks related to the polyester-based polyurethane (PE-PUR) sound abatement foam in specific CPAP, BiPAP and mechanical ventilator devices. At the time the recall notification/field safety notice* was issued, Philips Respironics relied on an initial, limited data set and toxicological risk assessment, and assumed a worst-case scenario for the possible health risks out of an abundance of caution. Since then, together with five certified, independent testing...

VANCOUVER, British Columbia, June 28, 2022 (GLOBE NEWSWIRE) — Teck Resources Limited (TSX: TECK.A and TECK.B, NYSE: TECK) (“Teck”) today announced a Carbon Capture Utilization and Storage (CCUS) pilot project at its Trail Operations metallurgical complex in southern British Columbia. The CCUS pilot is expected to begin operation in the second half of 2023. The CCUS pilot supports Teck’s Net-Zero Climate Change Strategy including our goal to reduce the carbon intensity of our operations by 33% by 2030 and achieve net-zero emissions by 2050. “This carbon capture pilot is an important step towards our knowledge building for the application of carbon capture, utilization and storage as an emissions reduction solution, as we work to evaluate pathways to reduce greenhouse gas emissions across our operations and achieve our net-zero goal,”...

WISeKey Announces the Divestiture of arago Zug, Switzerland, June 27, 2022 – Ad-Hoc announcement pursuant to Art. 53 of SIX Listing Rules – WISeKey International Holding Ltd. (“WISeKey” or the “Company”) (SIX: WIHN, NASDAQ: WKEY), a leading global cybersecurity, AI and IoT company, announced today that it has transferred its 51% controlling interest in arago GmbH (“arago”) to OGARA GmbH (“OGARA”). As previously announced on April 25, 2022, WISeKey signed a Share Purchase and Transfer Agreement to sell its 51% stake in arago to a German consortium of investors led by arago’s founder through his investment company, OGARA. The transfer of the shares gives OGARA full control of arago’s operations into the acquiring consortium, and establish the framework of the partnership between WISeKey and arago to work together on the increasing adoption...

The VENTANA DP 600 is Roche’s new, high-capacity slide scanner that creates high-resolution, digital images of stained tissue samples that help to diagnose cancer and determine a patient’s treatment. Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths.1 Many cancers can be cured if detected early and treated effectively.1 The Roche Digital Pathology solution helps empower the digital transformation of pathology and enable better, more personalised healthcare.Basel, 28 June 2022 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the CE launch of the next-generation VENTANA DP 600 slide scanner (CE-IVD marked). This high-capacity slide scanner produces excellent image quality of stained histology slides from patient tissue samples, while providing ease-of-use...

Ceftobiprole met primary and secondary efficacy endpoints Basilea plans to submit a New Drug Application (NDA) in the U.S. around year end 2022Ad hoc announcement pursuant to Art. 53 LR Basel, Switzerland, June 28, 2022 Basilea Pharmaceutica Ltd (SIX: BSLN), a commercial-stage biopharmaceutical company, announced today positive topline results for the phase 3 ERADICATE study, evaluating ceftobiprole in the treatment of adult patients with bacterial bloodstream infections caused by Staphylococcus aureus (SAB).1 Basilea is planning to submit a New Drug Application (NDA) for ceftobiprole to the U.S. Food and Drug Administration (FDA) around year end 2022. In accordance with the agreed Special Protocol Assessment (SPA), Basilea will seek approval for SAB and acute bacterial skin and skin structure infection (ABSSSI) indications based on...

MONTREAL, June 28, 2022 (GLOBE NEWSWIRE) — Bombardier Inc. (“Bombardier” or the “Corporation”) today announced certain matters with respect to its cash tender offer previously announced on June 13, 2022 (the “Tender Offer”) to purchase for cash up to US$350,000,000 aggregate purchase price (exclusive of Accrued Interest) (as such aggregate purchase price may be increased or decreased by the Corporation, the “Aggregate Maximum Purchase Amount”) of three series of its outstanding senior notes (collectively, the “Notes”) due 2027, 2024 and 2025 as identified in the Offer to Purchase (as defined below), subject to the Acceptance Priority Levels and the 2027 Tender Cap (as such 2027 Tender Cap may be increased or decreased by the Corporation), as applicable, and possible proration, as set forth in the Offer to Purchase containing the...

NEW YORK, New York, June 27, 2022 (GLOBE NEWSWIRE) — Ivanhoe Electric Inc. (“Ivanhoe Electric”), a U.S.-based minerals exploration and development company, announced today the pricing of its initial public offering of 14,388,000 shares of its common stock at a price of US$11.75 per share. The gross proceeds from the offering are expected to be approximately US$169.1 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by Ivanhoe Electric. In addition, Ivanhoe Electric has granted the underwriters a 30-day option to purchase up to an additional 2,158,200 shares of common stock at the initial public offering price, less underwriting discounts and commissions. The shares are expected to begin trading on the NYSE American and the Toronto Stock Exchange on June 28, 2022 under the ticker...

Pursued Claims Pursued Claims: Paid and Bill AmountCORAL GABLES, Fla., June 27, 2022 (GLOBE NEWSWIRE) — MSP Recovery, Inc. (“MSP Recovery” or “MSPR”), a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery and technology leader, today provided a business update.MSP has commenced sending individual claim demands totaling more than $5.6 billion in billed amounts for payments due from some of the largest pharmaceutical companies in the world. The total amounts billed against identified pharmaceutical companies related to more than twenty-five different types of recoveries.MSPR Identifies Additional Owned Claims Against Big Pharma MSPR today announced that it has identified more than $5.6 billion in billed amounts and more than $2.8 billion in paid amounts for unique potentially recoverable cases on behalf...

Approves spin-out of clinics business to Field Trip Health & Wellness Ltd., pending final court approval and additional customary closing conditions TORONTO, June 27, 2022 (GLOBE NEWSWIRE) — Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) (“Field Trip” or “Corporation”), a global leader in the development and delivery of psychedelic therapies, today announced that on June 27, 2022, its shareholders approved both the Arrangement Resolution, the Concurrent Financing Resolution and the SpinCo Incentive Plan Resolution (each as defined in the Circular (each as defined below)) at its special meeting of shareholders (the “Meeting”), thereby approving the previously announced spin-out of its clinics business to Field Trip Health & Wellness Ltd. (“Field Trip H&W”) by way of a...